Actively Recruiting
Long-term Follow-up of Patients With Spinal Muscular Atrophy Treated With OAV101 in Clinical Trials
Led by Novartis Pharmaceuticals · Updated on 2026-01-20
175
Participants Needed
32
Research Sites
427 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This is a global, prospective, multi-center study that is designed to assess the long-term safety and efficacy of OAV101 in patients who participated in an OAV101 clinical trial. The assessments of safety and efficacy in Study COAV101A12308 will continue for 5 years after enrollment in this study.
CONDITIONS
Official Title
Long-term Follow-up of Patients With Spinal Muscular Atrophy Treated With OAV101 in Clinical Trials
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Participated in an OAV101 clinical trial.
- Provided written informed consent before any assessments.
- Patient, parent, or legal guardian willing and able to follow study procedures.
You will not qualify if you...
History of severe allergic reactions to study medication Currently pregnant or breastfeeding Recent participation in another clinical trial within the last 30 days Presence of uncontrolled medical conditions that could affect safety
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 32 locations
1
Child Hosp Of The Kings Daughters
Norfolk, Virginia, United States, 23507
Actively Recruiting
2
Novartis Investigative Site
Sydney, New South Wales, Australia, 2031
Actively Recruiting
3
Novartis Investigative Site
Leuven, Belgium, 3000
Actively Recruiting
4
Novartis Investigative Site
Curitiba, Paraná, Brazil, 81520-060
Actively Recruiting
5
Novartis Investigative Site
São Paulo, São Paulo, Brazil, 05403 000
Actively Recruiting
6
Novartis Investigative Site
Montreal, Quebec, Canada, H4A 3J1
Actively Recruiting
7
Novartis Investigative Site
Chongqing, Chongqing Municipality, China, 400010
Actively Recruiting
8
Novartis Investigative Site
Guangzhou, Guangdong, China, 510623
Actively Recruiting
9
Novartis Investigative Site
Chengdu, Sichuan, China, 610041
Actively Recruiting
10
Novartis Investigative Site
Beijing, China, 100034
Actively Recruiting
11
Novartis Investigative Site
Beijing, China, 100069
Actively Recruiting
12
Novartis Investigative Site
Beijing, China, 100730
Actively Recruiting
13
Novartis Investigative Site
Copenhagen, Denmark, 2100 O
Actively Recruiting
14
Novartis Investigative Site
Bron, France, 69677
Actively Recruiting
15
Novartis Investigative Site
Garches, France, 92380
Actively Recruiting
16
Novartis Investigative Site
Strasbourg, France, 67000
Actively Recruiting
17
Novartis Investigative Site
Toulouse, France, 31059
Actively Recruiting
18
Novartis Investigative Site
Roma, RM, Italy, 00168
Actively Recruiting
19
Novartis Investigative Site
Kurume, Fukuoka, Japan, 830-0011
Actively Recruiting
20
Novartis Investigative Site
Shinjuku Ku, Tokyo, Japan, 1628666
Actively Recruiting
21
Novartis Investigative Site
Kuala Lumpur, Malaysia, 50300
Actively Recruiting
22
Novartis Investigative Site
Kuala Lumpur, Malaysia, 59100
Actively Recruiting
23
Novartis Investigative Site
Utrecht, Netherlands, 3584 CX
Actively Recruiting
24
Novartis Investigative Site
Riyadh, Saudi Arabia, 11211
Actively Recruiting
25
Novartis Investigative Site
Singapore, Singapore, 119074
Actively Recruiting
26
Novartis Investigative Site
Barcelona, Spain, 08035
Actively Recruiting
27
Novartis Investigative Site
Kaohsiung City, Taiwan, 80756
Actively Recruiting
28
Novartis Investigative Site
Taipei, Taiwan, 10002
Actively Recruiting
29
Novartis Investigative Site
Bangkok, Thailand, 10700
Actively Recruiting
30
Novartis Investigative Site
London, United Kingdom, WC1N 3JH
Actively Recruiting
31
Novartis Investigative Site
Newcastle upon Tyne, United Kingdom, NE1 4LP
Actively Recruiting
32
Novartis Investigative Site
Hanoi, Vietnam, 100000
Actively Recruiting
Research Team
N
Novartis Pharmaceuticals
CONTACT
N
Novartis Pharmaceuticals
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here